|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...4344454647484950515253...110111» |
- Recentin (cediranib) / AstraZeneca, Lynparza (olaparib) / Merck (MSD), AstraZeneca
Enrollment open, Trial initiation date, Trial primary completion date, PARP Biomarker: A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib (clinicaltrials.gov) - Jun 17, 2015
P2, N=5, Recruiting, Sponsor: University Health Network, Toronto
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Jun 2015 | Trial primary completion date: Jan 2017 --> Jun 2017
- Enrollment open: PET CT With HX4 in Cervix Cancer (clinicaltrials.gov) - Jun 17, 2015
P2, N=20, Recruiting, Sponsor: Maastricht Radiation Oncology
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Jun 2015 | Trial primary completion date: Jan 2017 --> Jun 2017 Not yet recruiting --> Recruiting
- Enrollment closed: Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer (clinicaltrials.gov) - Jun 17, 2015
P1, N=30, Active, not recruiting, Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial primary completion date: OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=200, Recruiting, Sponsor: Krankenhaus Barmherzige Schwestern Linz
Recruiting --> Active, not recruiting Trial primary completion date: May 2015 --> Dec 2015
- ||||| Enrollment closed: Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women (clinicaltrials.gov) - Jun 16, 2015
P3, N=700, Active, not recruiting, Sponsor: TherapeuticsMD
Trial primary completion date: May 2015 --> Dec 2015 Recruiting --> Active, not recruiting
- |||| Trial completion: Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (clinicaltrials.gov) - Jun 16, 2015
P2, N=256, Completed, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial primary completion date: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Jun 16, 2015
P1, N=15, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Trial primary completion date: Feb 2015 --> Feb 2016
- ||||||| Bravelle (urofollitropin) / Ferring
Trial completion, Head-to-Head: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program (clinicaltrials.gov) - Jun 16, 2015
P3, N=263, Completed, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Feb 2015 --> Feb 2016 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date, Surgery: Preoperative Warm-up in Gynecologic Surgery (clinicaltrials.gov) - Jun 16, 2015
P1, N=20, Completed, Sponsor: Medical University of Vienna
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Oct 2013 --> Mar 2014
- New trial, Surgery: Laparoscopic Surgery for Severe Recto-vaginal Endometriosis (clinicaltrials.gov) - Jun 15, 2015
P=N/A, N=1000, Recruiting, Sponsor: Royal Surrey County Hospital
- New trial, Preclinical: Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF) (clinicaltrials.gov) - Jun 15, 2015
P=N/A, N=780, Not yet recruiting, Sponsor: Vietnam National University
- ||| New trial, Biopsy: Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy (clinicaltrials.gov) - Jun 15, 2015
P=N/A, N=78, Not yet recruiting, Sponsor: University of South Florida
- New trial: RESMO: Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (clinicaltrials.gov) - Jun 15, 2015
P=N/A, N=90, Not yet recruiting, Sponsor: University Hospital, Strasbourg, France
- Enrollment change, Trial termination, Trial primary completion date: Autologous Endometrial Coculture (AECCT) (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=20, Terminated, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed | Trial primary completion date: Oct 2013 --> Mar 2014 N=224 --> 20 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Jun 2014; poor recruitment
- || Trial primary completion date, MRI: Preoperative Staging of Endometriosis With MRI (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=70, Recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
N=224 --> 20 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Jun 2014; poor recruitment Trial primary completion date: Sep 2015 --> Dec 2015
- | Leukine (sargramostim) / Partner Therap
New P1 trial: Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent (clinicaltrials.gov) - Jun 12, 2015
P1, N=20, Recruiting, Sponsor: Barbara Ann Karmanos Cancer Institute
- ||| Enrollment open, Trial primary completion date: Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=200, Recruiting, Sponsor: University of Oslo
Trial primary completion date: Sep 2015 --> Dec 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2013 --> Dec 2015
- Trial primary completion date: The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding (clinicaltrials.gov) - Jun 11, 2015
P3, N=50, Recruiting, Sponsor: Ain Shams Maternity Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2013 --> Dec 2015 Trial primary completion date: Apr 2015 --> Sep 2015
- zoliflodacin (ETX0914) / Entasis Therap, Global Antibiotic Research and Development Partnership
Trial primary completion date: Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea (clinicaltrials.gov) - Jun 11, 2015
P2, N=180, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Apr 2015 --> Sep 2015 Trial primary completion date: May 2015 --> Sep 2015
- || Trial primary completion date: Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=160, Recruiting, Sponsor: University of Aarhus
Trial primary completion date: May 2015 --> Sep 2015 Trial primary completion date: Apr 2015 --> Nov 2016
- || Biomarker, Preclinical, Trial primary completion date: Next Generation Sequencing Screening for Embryonic Ploidy Status (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=250, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Trial primary completion date: Apr 2015 --> Nov 2016 Trial primary completion date: Apr 2015 --> Dec 2015
- Trial primary completion date: Genetic Etiology in Premature Ovarian Insufficiency (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=100, Recruiting, Sponsor: BEGUM AYDOGAN
Trial primary completion date: Apr 2015 --> Dec 2015 Trial primary completion date: Jan 2015 --> Nov 2015
- Trial primary completion date: A Study of Human Chorionic Gonadotrophin as Luteal Phase Support in Frozen Embryo Transfer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=450, Recruiting, Sponsor: The University of Hong Kong
Trial primary completion date: Jan 2015 --> Nov 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=700, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2016 --> Sep 2016
- Trial primary completion date, Surgery: Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=130, Recruiting, Sponsor: Swedish Medical Center
Trial primary completion date: Mar 2016 --> Sep 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Prevalence of Polycystic Ovary Syndrome (PCOS) in Obese Premenopausal Women (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=500, Recruiting, Sponsor: Göteborg University
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Apr 2015 --> Dec 2015
- Enrollment change, Trial termination: Evaluation of the Endometrial Cavity After Endometrial Ablation (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=25, Terminated, Sponsor: Baylor Research Institute
Trial primary completion date: Apr 2015 --> Dec 2015 N=100 --> 25 | Recruiting --> Terminated; Sponsor and Principle Investigator mutually agreed to terminate study and patients are no longer examined/treated
- Enrollment change: Salivary Diagnostic Testing for IVF (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=1000, Enrolling by invitation, Sponsor: Boston IVF
N=100 --> 25 | Recruiting --> Terminated; Sponsor and Principle Investigator mutually agreed to terminate study and patients are no longer examined/treated N=500 --> 1000
- ethinyl estradiol/levonorgestrel / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive (clinicaltrials.gov) - Jun 11, 2015
P4, N=26, Terminated, Sponsor: University of California, Davis
N=500 --> 1000 N=130 --> 26 | Recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Aug 2015; Futility of recruitment
- Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date, HEOR: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=0, Withdrawn, Sponsor: Sheba Medical Center
N=130 --> 26 | Recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Aug 2015; Futility of recruitment N=60 --> 0 | Initiation date: Jun 2013 --> Aug 2014 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2014 --> Aug 2015
- ||||| Visanne (dienogest) / Mochida, Bayer
Enrollment change: Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients (clinicaltrials.gov) - Jun 11, 2015
P3, N=250, Active, not recruiting, Sponsor: Bayer
N=60 --> 0 | Initiation date: Jun 2013 --> Aug 2014 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2014 --> Aug 2015 N=175 --> 250
- Enrollment change, Trial withdrawal, Trial primary completion date: Ovarian Tissue Cryopreservation for Fertility Preservation (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=0, Withdrawn, Sponsor: Boston IVF
N=175 --> 250 N=100 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: May 2022 --> Mar 2015
- Trial primary completion date: Fermented Wheat Germ Extract in Women With Ovarian Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
N=100 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: May 2022 --> Mar 2015 Trial primary completion date: Dec 2015 --> Mar 2016
- Trial primary completion date: LACRING01: Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis (clinicaltrials.gov) - Jun 11, 2015
P1, N=6, Recruiting, Sponsor: University Ghent
Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- DCVAC/OvCa / Sotio
Trial primary completion date: SOV02: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma (clinicaltrials.gov) - Jun 11, 2015
P2, N=60, Active, not recruiting, Sponsor: Sotio a.s.
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2015 --> Dec 2016
- Trial primary completion date: Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=25, Active, not recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Mar 2015 --> Dec 2016 Trial primary completion date: Apr 2015 --> Apr 2016
- Trial primary completion date: Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma (clinicaltrials.gov) - Jun 11, 2015
P2, N=10, Recruiting, Sponsor: University Hospital, Gasthuisberg
Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Sep 2014 --> Oct 2015
- Trial primary completion date: WOMAN-PROII: The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence (clinicaltrials.gov) - Jun 11, 2015
P2, N=90, Recruiting, Sponsor: St.Gallen University of Applied Sciences
Trial primary completion date: Sep 2014 --> Oct 2015 Trial primary completion date: Apr 2015 --> Nov 2015
- Trial primary completion date: KCCP: The Kilimanjaro Cervical Screening Project (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=300, Recruiting, Sponsor: Queen's University
Trial primary completion date: Apr 2015 --> Nov 2015 Trial primary completion date: Mar 2015 --> Dec 2015
- || veliparib (ABT-888) / AbbVie
Trial primary completion date, BRCA Biomarker: A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors (clinicaltrials.gov) - Jun 11, 2015
P1, N=60, Active, not recruiting, Sponsor: AbbVie
Trial primary completion date: Mar 2015 --> Dec 2015 Trial primary completion date: Jan 2015 --> Feb 2016
- Trial primary completion date: VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=175, Recruiting, Sponsor: Rennes University Hospital
Trial primary completion date: Jan 2015 --> Feb 2016 Trial primary completion date: Jan 2015 --> Jan 2016
- defactinib (VS-6063) / Verastem
Trial primary completion date, Combination therapy, Metastases: Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer (clinicaltrials.gov) - Jun 11, 2015
P1, N=27, Active, not recruiting, Sponsor: Verastem, Inc.
Trial primary completion date: Jan 2015 --> Jan 2016 Trial primary completion date: May 2014 --> Dec 2015
- Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Trial primary completion date: May 2014 --> Dec 2015 Trial primary completion date: Sep 2014 --> Jul 2015
- Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Trial primary completion date: Sep 2014 --> Jul 2015 Trial primary completion date: Sep 2013 --> Sep 2015
- Trial primary completion date: Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer (clinicaltrials.gov) - Jun 11, 2015
P0, N=750, Recruiting, Sponsor: Swedish Medical Center
Trial primary completion date: Sep 2013 --> Sep 2015 Trial primary completion date: Aug 2015 --> Aug 2016
- Trial primary completion date: Lifestyle Intervention for Polycystic Ovary Syndrome: Pulse-Based Diet and Exercise (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=166, Recruiting, Sponsor: University of Saskatchewan
Trial primary completion date: Aug 2015 --> Aug 2016 Trial primary completion date: Dec 2013 --> Apr 2016
- || ethinyl estradiol/levonorgestrel / Generic mfg., naproxen / Generic mfg.
Trial primary completion date, HEOR: iTOM: Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia (clinicaltrials.gov) - Jun 11, 2015
P4, N=120, Active, not recruiting, Sponsor: Abimbola Famuyide
Trial primary completion date: Dec 2013 --> Apr 2016 Trial primary completion date: Dec 2014 --> Sep 2015
- Duomeisu (pegylated liposomal doxorubicin) / CSPC Pharma, veliparib (ABT-888) / AbbVie
Trial primary completion date, PARP Biomarker, Metastases: Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P1, N=58, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Dec 2014 --> Sep 2015 Trial primary completion date: Jun 2015 --> Dec 2015
- Trial primary completion date: Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: May 2015 --> May 2016
- Avastin (bevacizumab) / Roche
Trial primary completion date, Metastases: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer (clinicaltrials.gov) - Jun 11, 2015
P2, N=22, Active, not recruiting, Sponsor: University of Oklahoma
Trial primary completion date: May 2015 --> May 2016 Trial primary completion date: Jul 2015 --> May 2016